GlassScriptPhysician profile
Philip S Hatfield
NPI 1528248069
$5,608.36
in general payments reported to CMS, 2019-2025
15 companies · $412 in 2025
The $412 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,846 · 2020: $193 · 2021: $352 · 2022: $120 · 2023: $2,082 · 2024: $602 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759 · Travel and Lodging: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,759.37 |
| Travel and Lodging | $1,336.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,246.25 | 2019-2024 | Prostep, Ortholoc 2 Lapifuse, Augment Injectable |
| Pylant Medical | $1,868.53 | 2019-2023 | |
| Arthrex, INC. | $526.00 | 2019 | |
| Inari Medical, INC. | $198.24 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $178.76 | 2025 | Esprit |
| Treace Medical Concepts, INC. | $111.25 | 2025 | |
| P Bar Medical LLC | $102.16 | 2025 | |
| Paragon 28, INC. | $98.67 | 2021 | |
| Smith+Nephew, INC. | $95.51 | 2019-2022 | |
| Depuy Synthes Sales INC. | $56.71 | 2023-2025 | Fibergraft Bg Morsels, N/A, Motoband Cp |
| Averitas Pharma INC. | $49.03 | 2024 | Qutenza |
| Trilliant Surgical LLC. | $40.46 | 2021 | |
| Horizon Therapeutics Plc | $14.38 | 2023 | Krystexxa |
| Reprise Biomedical, INC. | $13.13 | 2024 | Miro3d |
| Grt US Holding, INC. | $9.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Hatfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.